ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
60,877.00
0.13%
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs Yen
155.775
-0.01%
Brent Oil
82.585
0.00%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Aileron Therapeutics Inc (ALRN)

  7. Aileron Therapeutics Inc (ALRN) ニュース

ALRN

Aileron Therapeutics (ALRN)

Aileron Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:ALRN
日付受信時刻ニュースソース見出しコード企業名
2024/05/0705 : 05GlobeNewswire Inc.Aileron Therapeutics to Present at Two Upcoming Investor ConferencesNASDAQ:ALRNAileron Therapeutics Inc
2024/05/0405 : 05GlobeNewswire Inc.Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 MillionNASDAQ:ALRNAileron Therapeutics Inc
2024/05/0121 : 45GlobeNewswire Inc.Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 MillionNASDAQ:ALRNAileron Therapeutics Inc
2024/05/0121 : 30GlobeNewswire Inc.Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)NASDAQ:ALRNAileron Therapeutics Inc
2024/04/1606 : 20GlobeNewswire Inc.Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:ALRNAileron Therapeutics Inc
2024/03/1221 : 00GlobeNewswire Inc.Aileron Therapeutics Announces CEO TransitionNASDAQ:ALRNAileron Therapeutics Inc
2024/03/0707 : 06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALRNAileron Therapeutics Inc
2024/02/2921 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALRNAileron Therapeutics Inc
2024/02/1606 : 05GlobeNewswire Inc.Aileron Therapeutics and Pulmonary Care Experts To Discuss the Potential Implications of LTI-03 for Idiopathic Pulmonary Fibrosis in Virtual Key Opinion Leader EventNASDAQ:ALRNAileron Therapeutics Inc
2024/02/1321 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALRNAileron Therapeutics Inc
2024/02/0614 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ALRNAileron Therapeutics Inc
2024/02/0603 : 20Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ALRNAileron Therapeutics Inc
2024/02/0206 : 30GlobeNewswire Inc.Aileron Therapeutics to Host Key Opinion Leader Event on February 15, 2024NASDAQ:ALRNAileron Therapeutics Inc
2024/02/0106 : 05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ALRNAileron Therapeutics Inc
2024/01/3006 : 15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ALRNAileron Therapeutics Inc
2024/01/3006 : 10Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ALRNAileron Therapeutics Inc
2024/01/2922 : 48Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ALRNAileron Therapeutics Inc
2024/01/2922 : 46Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ALRNAileron Therapeutics Inc
2024/01/2922 : 14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALRNAileron Therapeutics Inc
2024/01/2521 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALRNAileron Therapeutics Inc
2024/01/2006 : 44Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ALRNAileron Therapeutics Inc
2024/01/1206 : 18Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ALRNAileron Therapeutics Inc
2024/01/1106 : 08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALRNAileron Therapeutics Inc
2023/12/1907 : 56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALRNAileron Therapeutics Inc
2023/11/2206 : 43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALRNAileron Therapeutics Inc
2023/11/1622 : 05Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ALRNAileron Therapeutics Inc
2023/11/1407 : 08Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ALRNAileron Therapeutics Inc
2023/11/0309 : 55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALRNAileron Therapeutics Inc
2023/11/0309 : 50Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ALRNAileron Therapeutics Inc
2023/11/0309 : 47Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ALRNAileron Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ALRN

最近閲覧した銘柄

USOTC
ADDYY
Adidas (QX)
NYSE
KO
Coca Cola
NYSE
JPM
JP Morgan Chase
NYSE
MCD
McDonalds
AMEX
XLF
Financial Select Sector
AMEX
XLE
Energy Select Sector SPDR
USI
USTECH100
US Tech 100
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
GOOGL
Alphabet
FX
USDEUR
US Dollar vs Euro
NASDAQ
NVDA
NVIDIA
NASDAQ
TSLA
Tesla
NYSE
CVX
Chevron
NYSE
NKE
Nike
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有